CINECA IRIS Institutional Research Information System

DE FRANCIA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.887
EU - Europa 4.929
AS - Asia 2.189
SA - Sud America 114
AF - Africa 68
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.246
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.825
IT - Italia 1.592
CN - Cina 686
SG - Singapore 645
SE - Svezia 497
IE - Irlanda 441
DE - Germania 411
FR - Francia 342
DK - Danimarca 321
KR - Corea 231
UA - Ucraina 226
FI - Finlandia 185
JP - Giappone 145
GB - Regno Unito 143
AT - Austria 142
IN - India 124
PL - Polonia 114
VN - Vietnam 101
ES - Italia 85
LU - Lussemburgo 73
NL - Olanda 67
BR - Brasile 61
ID - Indonesia 53
RU - Federazione Russa 52
BE - Belgio 48
CA - Canada 48
AU - Australia 45
GR - Grecia 38
TR - Turchia 38
HK - Hong Kong 37
CZ - Repubblica Ceca 33
SN - Senegal 26
CH - Svizzera 22
AR - Argentina 20
TW - Taiwan 18
TH - Thailandia 16
IR - Iran 15
PT - Portogallo 15
HU - Ungheria 14
CO - Colombia 13
MX - Messico 12
SI - Slovenia 12
CL - Cile 11
HR - Croazia 11
IL - Israele 11
DZ - Algeria 10
PK - Pakistan 10
EG - Egitto 9
RO - Romania 9
RS - Serbia 9
UZ - Uzbekistan 8
IQ - Iraq 7
NZ - Nuova Zelanda 7
SY - Repubblica araba siriana 7
ZA - Sudafrica 7
JO - Giordania 6
MY - Malesia 6
SA - Arabia Saudita 6
MU - Mauritius 5
NO - Norvegia 5
BG - Bulgaria 4
EU - Europa 4
NG - Nigeria 4
PE - Perù 4
A1 - Anonimo 3
EC - Ecuador 3
LT - Lituania 3
LV - Lettonia 3
MK - Macedonia 3
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BY - Bielorussia 2
EE - Estonia 2
KW - Kuwait 2
MA - Marocco 2
PH - Filippine 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
GH - Ghana 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MC - Monaco 1
ME - Montenegro 1
MN - Mongolia 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
TG - Togo 1
UY - Uruguay 1
VE - Venezuela 1
Totale 14.246
Salva come PNG Salva come JPEG
Città #
Chandler 897
Ann Arbor 768
Singapore 545
Santa Clara 505
Dublin 427
Beijing 372
Fairfield 299
Torino 284
Ashburn 270
Houston 264
Turin 241
Nyköping 203
Wilmington 168
Woodbridge 147
Columbus 146
Villeurbanne 144
Redwood City 139
Jacksonville 135
Vienna 133
Dearborn 125
Seattle 125
Princeton 123
Medford 122
Cambridge 114
Milan 101
Warsaw 85
Pisa 72
Dudelange 66
Dong Ket 64
Fremont 57
New York 55
Munich 54
Jakarta 49
Boston 44
Guangzhou 40
Brussels 35
Rome 34
Boardman 32
Los Angeles 32
Shanghai 31
West Jordan 30
Brno 28
Florence 28
Tokyo 27
Padova 26
Paris 26
London 24
Würzburg 24
Düsseldorf 23
Hefei 23
San Diego 21
Helsinki 17
Nanjing 17
Hong Kong 16
Bethesda 15
Hangzhou 15
Bari 14
Catania 14
Chengdu 14
Toronto 14
Verona 14
Falls Church 13
Madrid 13
Phoenix 13
Seoul 13
Taipei 13
Washington 13
Bologna 12
Mont-saint-aignan 12
Pune 12
São Paulo 12
Amsterdam 11
Buenos Aires 11
Mumbai 11
Norwalk 11
Siena 11
Valencia 11
Chicago 10
Hebei 10
Jinan 10
Mountain View 10
Bogotá 9
Budapest 9
Hyderabad 9
Nürnberg 9
Canberra 8
Cork 8
Istanbul 8
Polska 8
Rotterdam 8
San Mateo 8
Shenyang 8
Zurich 8
Ankara 7
Fontenay-sous-bois 7
Kharkiv 7
Maastricht 7
Osaka 7
Palermo 7
San Francisco 7
Totale 8.358
Salva come PNG Salva come JPEG
Nome #
Practical treatment using mitotane for adrenocortical carcinoma. 761
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 432
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. 422
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 400
Management of adjuvant mitotane therapy following resection of adrenal cancer. 329
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 323
La Medicina delle differenze. Storie di donne, uomini e discriminazioni. 283
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). 279
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 265
Subchronic nandrolone administration reduces cardiac oxidative markers during restraint stress by modulating protein expression patterns. 263
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 257
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. 225
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 203
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 195
Intense physical exercise increases systemic 11b-hydroxysteroid dehydrogenase type 1 activity in healty adult subjects 193
Single-Nucleotide Polymorphisms of ABCB1 Gene Influence Intracellular Concentrations of Dasatinib. 184
PHARMACOGENETIC DETERMINANTS OF PLASMATIC AND INTRACELLULAR TYROSINE KINASE INHIBITORS 177
Role of pharmacogenetics on deferasirox AUC and efficacy 175
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia 173
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 169
Procedimento cromatografico di dosaggio di DDT, DDD, DDA, e DDE 166
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 162
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib 158
Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines 158
Role of Cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 156
Il diritto alla scienza medica e le questioni di genere in Così San Tuttə. Diritto alla scienza: istruzioni per l’uso. 156
Steroid resistance in nasal polyposis: role of glucocorticoid receptor and TGF-beta1. 145
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 144
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 144
11betahydroxysteroid dehydrogenase type 1 and 2 activities in bone fragments of patients with rheumatoid arthritis 143
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 139
"Procedimento per determinare glifosato e acido aminometilfosfonico in un campione" 137
Role of cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 135
In vitro enhancement of anticancer activity of paclitaxel by a Cremophor free cyclodextrin-based nanosponge formulation 132
Differential patterns of glucocorticoid receptors and 11beta hydroxysteroid dehydrogenase activity in androgen-dependent and androgen-independent prostate cancer cell lines. Relevance to glucocorticoid sensitivity. 131
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 127
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 127
Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant. 126
Malattia di Alzheimer: prototipo di malattia di genere? 123
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 118
La recidiva di carcinoma del cortico-surrene:trattamento chirurgico o chemioterapico? 115
Biological and molecular effects of high doses of anabolic steroids 115
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 111
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 110
Efficacy of repeat surgery in patients with recurrent adrenocortical cancer (ACC) 109
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 107
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 106
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 106
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients 104
A prospective study on adjuvant mitotane 103
The San Luigi hospital experience with adjuvant mitotane treatment in patients with adrenocortical cancer following radical resection 97
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 97
Deferasirox AUC efficacy cutoff and role of pharmacogenetics 95
Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients 94
Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results? 91
Cremophor free cyclodextrin-based nanosponge formulation for the delivery of paclitaxel 89
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness. 88
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 88
L'esperienza dell'ospedale san Luigi nel trattamento con mitotane adiuvante in pazienti operati radicalmente per carcinoma corticosurrenalico. 86
NURR1 deficiency is associated to ADHD-like phenotypes in mice 85
Influence of single-nucleotide polymorphisms on deferasirox C-trough levels and effectiveness 84
Clinical relevance of deferasirox trough levels in β-thalassemia patients 84
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 84
COVID-19 infection: ACE2, pregnancy and preeclampsia 82
The influence of sex, gender and age on COVID-19 data in the Piedmont region: the virus prefers men 82
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 81
New hplc–uv validated method for therapeutic drug monitoring of antifungal agents in acute myeloid leukemia 81
Quantification of imatinib plasma levels in patients with chronic myeloid leukemia: Comparison between HPLC-UV and LC-MS/MS 81
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 79
Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring 79
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients 77
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome 77
Effects of germline CYP2W1*6 and CYP2B6*6 single nucleotide polymorphisms on mitotane treatment in adrenocortical carcinoma: A multicenter ENSAT study 77
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 76
Determinanti farmacogenetici della farmacocinetica del mitotane: studio condotto su pazienti affetti da carcinoma corticosurrenalico 76
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 76
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants 76
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma 72
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 71
EVALUTATION OF THE CONTROL OF PAIN IN PATIENTS WITH BONE METASTASIS UNDERGOING MEDICAL TREATMENT WITH BISPHOSPHONATES 70
GENDER ANALYSIS ON COVID-19 DATA IN PIEMONTE: THE VIRUS PREFERS MEN 70
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 69
EFFECT OF SEASONS ON FOUR ANTI-EPILEPTIC DRUGS PLASMA LEVELS 69
Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib. 68
Mitotane 67
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. 67
Sex-tailored pharmacology and COVID-19: next steps towards appropriateness and health equity 67
DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR OROTIC ACID AND OROTIDINE 5’-MONOPHOSPHATE DETECTION IN HUMAN PLASMA AND URINE 65
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 64
A current perspective on treatment of adrenocortical carcinoma 63
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 63
Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics 62
Salicylate counteracts streptozotocin induced diabetes mellitus in rat 60
THE ROLE OF SURGERY IN THE MANAGEMENT OF RECURRENT ADRENOCORTICAL CARCINOMA: RESULTS OF A RETROSPECTIVE STUDY 59
“La salute è un diritto di genere" 58
Mineralcorticoidi 58
Mitotane treatment for adrenocortical carcinoma: an overview. 58
La fluidità dei confini: il diritto alla salute ha un genere? 57
NURR1-deficient mice have age- and sex-specific behavioral phenotypes 56
Procedimento per determinare glifosato e acido aminometilfosfonico in un campione 54
Totale 13.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.323
article - articoli 0
book - libri 0
conference - conferenze 14.381
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.704
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.226 0 0 0 0 0 307 174 122 140 189 134 160
2020/20211.436 167 109 69 72 118 113 98 61 141 106 152 230
2021/20222.256 113 129 134 192 143 166 180 170 105 187 417 320
2022/20232.750 249 269 122 269 237 655 159 176 284 73 179 78
2023/20241.446 163 200 123 77 108 133 55 64 40 134 141 208
2024/20251.973 112 207 183 353 869 249 0 0 0 0 0 0
Totale 14.804